HS-10
Cost-Efficient Model Equipped with the Functions Needed for Headspace Analysis
The HS-10 headspace sampler is highly cost efficient, yet is equipped with advanced features such as a mixing function and the ability to heat-ahead the sample vials waiting for analysis. This instrument is the perfect platform for the analysis of residual pharmaceutical solvents and trace VOCs in wastewater.
Category:
Producer:
Product Description
Cost-Efficient Model Equipped with the Functions Needed for Headspace Analysis
The HS-10 headspace sampler is highly cost efficient, yet is equipped with advanced features such as a mixing function and the ability to heat-ahead the sample vials waiting for analysis. This instrument is the perfect platform for the analysis of residual pharmaceutical solvents and trace VOCs in wastewater.
Technical specifications
Features
Outstanding Reproducibility
Favorable area reproducibility can be obtained, thanks to high-accuracy flow rate control by electronic flow controllers (AFC and APC), and a thermostatic vial chamber with a uniform temperature distribution.
The temperature in the thermostatic vial chamber is uniform; as a result, there is no variance in gas-liquid equilibrium depending on intake position.
Reproducibility for 0.4 % Ethanol 2.0 % (n = 10)
Overlap Analysis
During a GC analysis, the HS-10 will take the next vial and move it to the vial heater. There, it can incubate for a specified time and be ready for injection when the previous analysis cycle has ended.
Mixing Function
The HS-10 is equipped with the ability to mix each vial by shaking. This allows the headspace concentration within each sample to come to equilibrium sooner, ultimately saving time and increasing throughput.
Vials are mixed by moving them up and down.
Compatible with the LabSolutions Comprehensive Workstation
LabSolutions LC/GC software integrates the conventional programs LCsolution and GCsolution. With a user control function and an audit trail function for method parameters, LabSolutions can accommodate a variety of regulations, including directives related to FDA 21 CFR Part 11.
